Literature DB >> 12229973

Intrahepatic heterogeneity of hepatic venous pressure gradient in human cirrhosis.

S Keiding1, H Vilstrup.   

Abstract

BACKGROUND: The hepatic venous pressure gradient (HVPG) is used to evaluate portal hypertension.
METHODS: We measured HVPG in two separate liver veins in 169 liver vein catheterizations in 102 cirrhosis patients and in 27 patients with no liver disease (controls).
RESULTS: In the controls, the two measurements differed by 0.0 +/- 1.8 mmHg (mean +/- s, n = 27), upper 95% confidence limit 3.6 mmHg (mean + 2 s). HVPG ranged from -0.1 to 8.3 mmHg, upper 95% confidence limit 6.7 mmHg. In cirrhosis, the two measurements agreed within +/- 3.6 mmHg in 39%. In 61%, the measurements differed by 4-34 mmHg. In 35%, fluoroscopy demonstrated hepatic vein-to-hepatic-vein shunting in veins with low HVPG values. In some patients with HVPG measurements above 30 mmHg, Doppler ultrasound examination showed arterialization of the hepatic vasculature. DISCUSSION: Our results demonstrate a hitherto unrecognized notable heterogeneity of the intrahepatic vasculature and HVPG measurements in cirrhosis. The presumption of interposition of non-flowing blood between the catheter tip and the portal system for the measurement of HVPG may thus be violated in about one-third of the cirrhosis cases because of abnormal outlet into hepatic venous shunts and in a minor fraction because of abnormal arterial inlet. In 26%, one measurement was below 12 mmHg, the other measurement above. If the HVPG had been measured in only one liver vein, 13% of the cases would have been classified in a lower risk group than appropriate according to the 12 mmHg concept of risk of bleeding from oesophageal varices.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12229973     DOI: 10.1080/003655202760230946

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  9 in total

Review 1.  Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectives.

Authors:  Beom Kyung Kim; James Fung; Man-Fung Yuen; Seung Up Kim
Journal:  World J Gastroenterol       Date:  2013-03-28       Impact factor: 5.742

2.  Hemodynamics and pharmacokinetics of tezosentan, a dual endothelin receptor antagonist, in patients with cirrhosis.

Authors:  Didier Lebrec; Jaime Bosch; Rajiv Jalan; Francis J Dudley; Rada Jessic; Richard Moreau; Juan Carlos Garcia-Pagan; Rajeshwar P Mookerjee; Eleonora Chiossi; Paul L M Van Giersbergen; Andjela Kusic-Pajic; Jasper Dingemanse
Journal:  Eur J Clin Pharmacol       Date:  2011-11-20       Impact factor: 2.953

3.  Hepatic blood perfusion measured by 3-minute dynamic 18F-FDG PET in pigs.

Authors:  Michael Winterdahl; Ole Lajord Munk; Michael Sørensen; Frank Viborg Mortensen; Susanne Keiding
Journal:  J Nucl Med       Date:  2011-06-16       Impact factor: 10.057

Review 4.  Monitoring target reduction in hepatic venous pressure gradient during pharmacological therapy of portal hypertension: a close look at the evidence.

Authors:  U Thalheimer; M Mela; D Patch; A K Burroughs
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

5.  Hepatic ethanol elimination kinetics in patients with cirrhosis.

Authors:  Gitte Dam; Michael Sørensen; Ole Lajord Munk; Susanne Keiding
Journal:  Scand J Gastroenterol       Date:  2009       Impact factor: 2.423

6.  Comparison of hepatic venous pressure gradient and endoscopic grading of esophageal varices.

Authors:  EunJi Lee; Yong Jae Kim; Dong Erk Goo; Seung Boo Yang; Hyun-Joo Kim; Jae Young Jang; Soung Won Jeong
Journal:  World J Gastroenterol       Date:  2016-03-21       Impact factor: 5.742

Review 7.  The clinical use of HVPG measurements in chronic liver disease.

Authors:  Jaime Bosch; Juan G Abraldes; Annalisa Berzigotti; Juan Carlos García-Pagan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-09-01       Impact factor: 46.802

Review 8.  Liver-related effects of chronic hepatitis C antiviral treatment.

Authors:  Tea L Laursen; Thomas D Sandahl; Konstantin Kazankov; Jacob George; Henning Grønbæk
Journal:  World J Gastroenterol       Date:  2020-06-14       Impact factor: 5.742

9.  Incidence and hemodynamic feature of risky esophageal varices with lower hepatic venous pressure gradient.

Authors:  Hitoshi Maruyama; Kazufumi Kobayashi; Soichiro Kiyono; Sadahisa Ogasawara; Yoshihiko Ooka; Eiichiro Suzuki; Tetsuhiro Chiba; Naoya Kato; Yasuyuki Komiyama; Masashi Takawa; Hiroaki Nagamatsu; Shuichiro Shiina
Journal:  Int J Med Sci       Date:  2019-11-09       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.